Sponsored Content
Subscribe and receive the latest insights on the healthy food and beverage industry.
Join 47,000+ member. Yes, it's completely free.
- Sponsored Content
- Manufacturing
Navigating Regulatory Expectations for Extractables and Leachables of Combination Products
BPI Contributor
September 4, 2019
20 Min View
Date: Sep 4, 2019
Duration: 20 Min
Already have an account?
Sponsored by WuXi Advanced Therapies
This webcast is no longer available.
This webcast features: Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi AppTec
The expectations for extractables and leachables of medical devices (delivery systems) are different than those of typical pharmaceutical applications such as container closure systems or single use systems. Learn about how the FDA reviews combination products and learn about testing expectations. Put these expectations to practice with a case study review complete including common pitfalls in testing.
Key lessons learned:
How does the FDA interact internally when reviewing combination products?
How is characterization of delivery devices different than container closures or single-use systems?
Why is complete characterization important?
This webcast is no longer available.
About the Author
You May Also Like
Webinars
Sponsored Content
Jun 5 - Jun 6, 2024
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More
